See also this year's filing and all EDGAR filings for this company.
PDF Report 0001583107_2019_Theravance_Biopharma_Inc.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001583107, Theravance Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 532,823,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 13,176,000 |
| 3 | remainder_Assets | 14,236,000 |
| 4 | LiabilitiesCurrent | 98,554,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 97,058,000 |
| 9 | ResearchAndDevelopmentExpense | 201,348,000 |
| 10 | remainder_Expenses | 636,000 |
| 11 | remainder_Revenues | 60,370,000 |
| 12 | remainder_NetIncome | 23,148,000 |
| 13 | remainder_ComprehensiveNetIncome | 567,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 560,235,000 |
| 1 | Liabilities | 98,554,000 |
| 2 | Expenses | 299,042,000 |
| 3 | Revenues | 60,370,000 |
| 4 | StockholdersEquity | 461,681,000 |
| 5 | NetIncome | -215,524,000 |
| 6 | ComprehensiveNetIncome | -215,240,500 |
| 7 | BaseVar | 520,958,000 |
| 8 | EconomicCapitalRatio | 1.76 |
Edgar->Model Mapping
Feature Distribution
Change over Time
